aripiprazole has been researched along with nortriptyline in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Blumberger, DM; Brown, PJ; Cristancho, P; Karp, JF; Lavretsky, H; Lenard, E; Lenze, EJ; Miller, JP; Montes-Garcia, C; Mulsant, BH; Reynolds, CF; Rollman, BL; Roose, SP | 1 |
| Blumberger, DM; Brown, PJ; Cristancho, P; Flint, AJ; Gebara, MA; Gettinger, TR; Karp, JF; Lavretsky, H; Lenard, E; Lenze, EJ; Miller, JP; Mulsant, BH; Nicol, GE; Oughli, HA; Pham, VT; Reynolds, CF; Rollman, BL; Roose, SP; Yang, L | 1 |
| Bosch, TM; Liang, J; Mitrov-Winkelmolen, L; van den Bout, CJ | 1 |
| Ebell, MH | 1 |
1 review(s) available for aripiprazole and nortriptyline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for aripiprazole and nortriptyline
| Article | Year |
|---|---|
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM): Study Design and Treatment Characteristics of the First 396 Participants Randomized.
Topics: Aged; Antidepressive Agents; Aripiprazole; Bupropion; Depressive Disorder, Treatment-Resistant; Humans; Lithium Compounds; Multicenter Studies as Topic; Nortriptyline; Pragmatic Clinical Trials as Topic; Treatment Outcome | 2019 |
Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression.
Topics: Aged; Antidepressive Agents; Aripiprazole; Bupropion; Depression; Drug Therapy, Combination; Humans; Lithium Compounds; Nortriptyline; Treatment Switching | 2023 |
5 other study(ies) available for aripiprazole and nortriptyline
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Delayed Lithium Reintoxication in a Case of Severe Multidrug Intoxication: A Case Study.
Topics: Aripiprazole; Continuous Renal Replacement Therapy; Humans; Lithium; Nortriptyline | 2023 |
Augmentation With Aripiprazole or Bupropion, or a Switch to Nortriptyline, Effective for Treatment-Resistant Depression in Older Adults.
Topics: Aged; Aripiprazole; Bupropion; Depression; Depressive Disorder, Treatment-Resistant; Humans; Nortriptyline | 2023 |